相关实验视频
Updated: Jun 11, 2025

07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
43
自主反应性B细胞仍然活跃,尽管在类风湿性关节炎的临床疾病控制
Sam Neppelenbroek1, Nienke J Blomberg1, Arieke S B Kampstra1
1Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands.
Journal of autoimmunity
|September 29, 2024
概括
在类风湿性关节炎 (RA) 中,即使疾病得到控制时,抗素蛋白抗体 (ACPA) B 细胞仍然活跃,这表明没有缓解. 这种持续的活动可能解释了为什么RA患者在无药缓解方面扎,并且经常出现爆发.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 自免疫性疾病 自免疫性疾病
背景情况:
- 自身免疫性疾病 (AID) 涉及自身反应性B细胞反应,但它们的动态和与人类临床活动的关系尚不清楚.
- 类风湿性关节炎 (RA) 是一种原型的AID,其特征是B细胞对素蛋白的反应.
研究的目的:
- 确定ACPA阳性 (ACPA+) RA患者B细胞反应活性和临床疾病活性之间的关系.
主要方法:
- 流细胞计分析了ACPA +,毒素 (TT) +和ACPA-记忆B细胞 (MBC) 上的B细胞激活标记,这些B细胞来自接受各种治疗的ACPA + RA患者.
- 结果与临床疾病活性相关.
主要成果:
- 与TT+和ACPA-MBCs相比,ACPA+MBCs显示出高度活化的表型 (Ki-67,CD86,CD80,CD19,CD20增加;CD32减少).
- 在横截面或纵向分析中,这种激活的表型与临床疾病活性没有相关性,即使是用氏激酶 (JAK) 抑制剂治疗.
结论:
- 在多次干预中,ACPA+ MBC 保持活力,尽管在RA 患者的临床疾病控制.
- 这种持续的活动表明免疫性缓解缺乏,并可能解释难以实现持续无药缓解和在药物逐渐减少时频繁爆发的困难.
相关概念视频
T Cell Types and Functions
959
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
959
B Cell Activation and Differentiation
1.6K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.6K
Autoimmune Disorders
394
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
394
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Cells of the Adaptive Immune Response
969
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
969
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
117
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
117

